CURING CANCER

…BY TARGETING CANCER UNIVERSAL CARBOHYDRATE STRUCTURE

Var2 Pharmaceuticals

... is a privately held biotechnology company engaged in the design and development of proprietary therapeutic proteins targeting cancer-specific carbohydrate structures for multiple cancer indications.

ABOUT VAR2 PHARMACEUTICALS

VAR2 Pharmaceuticals is a privately held biotechnology company engaged in the design and development of proprietary therapeutic proteins targeting cancer-specific carbohydrate structures for multiple cancer indications. We have a portfolio of proteins with unique affinity and specificity for these cancer-associated carbohydrates for the development of treatments for cancers where there is no effective therapy, such as sarcoma, triple negative breast cancers and prostate cancer.

 

The technology is based on groundbreaking discoveries made by researchers at University of Copenhagen, Denmark, in collaboration with partners at University of British Columbia, Canada.

VarCT Diagnostics

... is engaged in the design and development of novel technology for capturing and analysis of circulating tumor cells of diverse origin, ultimately aiming for methods that will allow early screening and detection of all types of cancer

VAR2 Pharmaceuticals ApS

Ole Maaløes Vej 3
DK-2200 Copenhagen N
CVR: 34621942

T: +45 78 70 19 00